Mathew S. Maurer
0000-0001-5400-5008
Publication & Citation Trends
Publications
0 total
Development of Imaging Endpoints for Clinical Trials in AL and ATTR Amyloidosis OA
Cited by 4
Semantic Scholar
Early Increase in Serum Transthyretin by Acoramidis Independently Predicts Improved Survival in TTR Amyloid Cardiomyopathy.
Cited by 23
Semantic Scholar
Acoramidis for Transthyretin Amyloid Cardiomyopathy: Open-Label Extension Study Long-Term Follow-Up. OA
Cited by 5
Semantic Scholar
The FLC Ratio Reframed
Cited by 0
Semantic Scholar
Efficacy of Acoramidis in Wild-Type and Variant Transthyretin Amyloid Cardiomyopathy
Cited by 1
Semantic Scholar
Timing of Mortality Benefit in Outcomes Trials in Transthyretin Amyloidosis.
Cited by 3
Semantic Scholar
Clinical Phenotype and Prognostic Significance of Frailty in Transthyretin Cardiac Amyloidosis OA
Cited by 14
Semantic Scholar
Research Topics
Amyloidosis: Diagnosis, Treatment, Outcomes
(320)
Parathyroid Disorders and Treatments
(169)
Cardiovascular Function and Risk Factors
(80)
Heart Failure Treatment and Management
(49)
Eosinophilic Disorders and Syndromes
(48)
Affiliations
American College of Cardiology
Boston University
Northwestern University
Twitter (United States)
Brigham and Women's Hospital